moxalactam - CISMeF

Preferred Label : moxalactam;

MeSH definition : Broad- spectrum beta-lactam antibiotic similar in structure to the CEPHALOSPORINS except for the substitution of an oxaazabicyclo moiety for the thiaazabicyclo moiety of certain CEPHALOSPORINS. It has been proposed especially for the meningitides because it passes the blood-brain barrier and for anaerobic infections.;

MeSH synonym : Latamoxef; lamoxactam;

MeSH hyponym : moxalactam disodium; shiomarin; 6059-S; lilly 127935; 1-Oxacephalosporin; festamoxin; 6059 S; 6059S; S-6059; S 6059; S6059; Ly-127935; Ly 127935; Ly127935; 1 Oxacephalosporin; Disodium, Moxalactam; Disodium Latamoxef; Latamoxef, Disodium; Disodium Moxalactam; Moxalactam, Disodium;

MeSH CAS label : 5-Oxa-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((carboxy(4-hydroxyphenyl)acetyl)amino)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-;

MeSH Related Number : 64952-97-2 (Moxalactam); moxalactam disodium; 5APW73W3QZ;

Registry Number MeSH : 64952-97-2;

Related CAS MeSH : 5APW73W3QZ (Moxalactam disodium);

Wikipedia link : https://en.wikipedia.org/wiki/Latamoxef;

Codes EINECS : 265-287-9;

Is substance : O;

UNII : VUF6C936Z3;

InChIKey : JWCSIUVGFCSJCK-CAVRMKNVSA-N;

Détails

Origin ID

D009070;

UMLS CUI

C0026651;

ATC code(s)
- latamoxef [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
CISMeF manual mappings
- Latamoxef poisoning (disorder) [SNOMED CT concept]
- moxalactam [Substance BNPC]
Pharmacological action(s)
- anti-bacterial agents [MeSH Descriptor]
Record concept(s)
- 1-Oxacephalosporin [MeSH concept]
- 6059-S [MeSH concept]
- festamoxin [MeSH concept]
- lilly 127935 [MeSH concept]
- moxalactam [MeSH concept]
- moxalactam disodium [MeSH concept]
- shiomarin [MeSH concept]
Semantic type(s)
- Antibiotic [UMLS semantic type]
- Organic Chemical [UMLS semantic type]
UMLS correspondences (same concept)
- Latamoxef (substance) [SNOMED CT concept]
- Moxalactam [NCIt concept]
- Moxalactam [LOINC component]
- Product containing latamoxef (medicinal product) [SNOMED CT concept]
- latamoxef [ATC Code]
- moxalactam [Substance BNPC]
- moxalactam [SNOMED Notion]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients